← Back to Search

Behavioural Intervention

Online Assessment and Treatment for Asthma/COPD

N/A

Waitlist Available

Led By Kathy Vandemheen

Research Sponsored by Ottawa Hospital Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Individual must be able to perform pre and post bronchodilator spirometry to measure lung function

Individuals at least 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial assesses an online questionnaire to identify Canadians with undiagnosed asthma/COPD and invites them to get treatment to improve their quality of life.

Who is the study for?

This trial is for adults who suspect they might have asthma or COPD based on respiratory symptoms. They must be able to perform lung function tests and score a ≥6% chance of having these conditions using an online questionnaire. It's not for those already diagnosed with significant lung diseases, using certain inhaled medications, under specialist care, or with recent serious cardiovascular events.Check my eligibility

What is being tested?

The study evaluates if treating undiagnosed asthma or COPD following guidelines improves life quality and health outcomes. Participants identified at risk from an online survey will receive assessments and treatments by a respirologist according to evidence-based standards.See study design

What are the potential side effects?

Since the interventions involve standard treatments for asthma or COPD as per guidelines, side effects may include throat irritation, hoarseness, coughing, headaches, oral thrush infections and potentially increased heart rate; specific side effects depend on the exact treatment prescribed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can do breathing tests before and after using a bronchodilator.

Select...

I am 18 years old or older.

Select...

I am experiencing symptoms related to my breathing.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in disease-specific quality of life quantified using the St. George's Respiratory Questionnaire (SGRQ).

Secondary outcome measures

Change in dyspnea as assessed by The Baseline and Transitional Dyspnea Indexes

Changes in absenteeism and presenteeism as assessed by the Work Productivity and Activity Impairment Questionnaire (WPAI)

Changes in forced expiratory volume in one second (FEV1) measured in litres (L) using pre bronchodilator spirometry testing and post bronchodilator spirometry testing.

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Delayed diagnosis and treatment of COPD or AsthmaExperimental Treatment1 Intervention

Treatment strategy using evidence-based guidelines for asthma or COPD provided to participant at 12 weeks.

Group II: Early diagnosis and treatment of COPD or AsthmaActive Control1 Intervention

Treatment strategy using evidence-based guidelines for asthma or COPD provided to participant on the day of randomization

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,344 Previous Clinical Trials

26,453,217 Total Patients Enrolled

Ottawa Hospital Research InstituteLead Sponsor

561 Previous Clinical Trials

2,785,491 Total Patients Enrolled

Kathy VandemheenPrincipal InvestigatorOttawa Hospital Research Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this scientific investigation presently enrolling participants?

"Data visible on clinicaltrials.gov affirms that this study is no longer recruiting patients; the trial was first posted September 1st, 2023 and last updated August 24th of the same year. Fortunately, there are 604 other trials actively accepting participants currently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The UCAP 2 Pilot Study

2023. "The UCAP 2 Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06014840.

All > Pediatric Asthma > Asthma